Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets

Acute myeloid leukemia (AML) is an aggressive and often fatal hematopoietic malignancy. A very attractive way to treat myeloid leukemia, called “differentiation therapy”, was proposed when in vitro studies showed that some compounds are capable of inducing differentiation of AML cell lines. One of t...

Descripción completa

Detalles Bibliográficos
Autor principal: Marcinkowska, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320351/
https://www.ncbi.nlm.nih.gov/pubmed/35889808
http://dx.doi.org/10.3390/nu14142851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320351/
https://www.ncbi.nlm.nih.gov/pubmed/35889808
http://dx.doi.org/10.3390/nu14142851

Ejemplares similares